Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades

Liu et al. (Sun,) studied this question.

www.synapsesocial.com/papers/69da690c0d540cafc5839079 — DOI: https://doi.org/10.1002/cam4.3037

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016· 2016 · 141 citations
2. Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data· 2016 · 24 citations
3. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project· 2018 · 155 citations
4. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016· 2017 · 4,914 citations
5. Improving Survival of Patients With Hodgkin Lymphoma Over 4 Decades: Experience of the British National Lymphoma Investigation (BNLI) With 6834 Patients· 2016 · 14 citations